Scott Hirsch - 31 Jul 2025 Form 3 Insider Report for Mallinckrodt plc

Role
Director
Signature
/s/ Mark Tyndall, Attorney-in-Fact
Transactions as of
31 Jul 2025
Transactions value $
$0
Form type
3
Filing time
04 Aug 2025, 20:44:25 UTC
Next filing
18 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hirsch Scott Director 675 MCDONNELL BLVD., HAZELWOOD /s/ Mark Tyndall, Attorney-in-Fact 04 Aug 2025 0002024619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Ordinary Shares 455 31 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the "Transaction Agreement"), by and among Mallinckrodt plc (the "Issuer"), Endo, Inc. ("Endo") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary ("Merger Sub"), the Merger Sub merged with and into Endo (the "Business Combination"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. At the Merger Effective Time (as defined in the Transaction Agreement), each share of Endo common stock held by the reporting person immediately prior to the Merger Effective Time automatically converted into the right to receive approximately $1.31 in cash and 0.2575 ordinary shares of the Issuer without interest and subject to applicable withholding. The securities reported herein were acquired by the reporting person prior to the reporting person becoming a director of the Issuer.
F2 The reporting person became a director of the Issuer immediately following the effective time of the Business Combination.

Remarks:

Exhibit 24 - Power of Attorney. This Form 3 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.